Disease Info Card

Ovarian Granulosa Cell Tumor

Information about Ovarian Granulosa Cell Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Ovarian Granulosa Cell Tumor

Most recent studies have shown that Ovarian Granulosa Cell Tumor shares some biological mechanisms with adenocarcinoma, carcinoma, endometrial-carcinoma, endometrial-polyp, granulosa-cell-tumor, hemorrhage, hyperplasia, juvenile-type-granulosa-cell-tumor, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neoplasms-multiple-primary, ovarian-neoplasm, pain, precocious-puberty, recurrence-(disease-attribute), thecoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Ovarian Granulosa Cell Tumor, and have been seen in publications frequently: Angiogenesis, Cell Differentiation, Cell Growth, Cell Proliferation, Diestrus, Enucleation, Localization, Luteinization, Luteolysis, Menopause, Menstruation, Mitosis, Muscle Hyperplasia, Ovulation, Pathogenesis, Reverse Transcription, Secretion, Smooth Muscle Hyperplasia, Transposition

Quite a number of genes have been found to play important roles in Ovarian Granulosa Cell Tumor, such as AMH, AMHR2, BRD2, CALB2, CD99, CEL, CTLA4, CTNNB1, CYP19A1, ESR1, NOD2, PGR, PLOD1, PRL, PTEN, TP53, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.